/Investor DB

Propel Bio Partners — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Inherentinherentlaboratories.comSep 2022

Inherent is an AI research lab, incorporated as a Public Benefit Corporation, developing general-purpose inventive AI systems and "AI Scientist" agents intended to accelerate research and power autonomous labs.

AI & Machine LearningDeep TechEnterprise Software

Tantum Collinsin

Co-investorsIndex VenturesRadical VenturesEx/AnteMacroscopic VenturesMetaplanetMythos Ventures Management, Llc

Inherentinherentlabs.aiSep 2022

Inherent develops general-purpose AI agents designed to augment scientific research and discovery across disciplines.

AI & Machine LearningDeep Tech

Louis Kirsch(Founder)inTantum Collins(Founder)inEdward Hughes(Founder)Kaloyan Aleksiev(Founder)

Co-investorsMythos Ventures Management, LlcEx/AnteIndex VenturesMacroscopic VenturesMetaplanetRadical Ventures

Inherent Biosciencesinherentbio.cominSep 2022

Inherent Biosciences develops clinical diagnostic solutions using epigenetics and AI to address complex healthcare concerns.

AI & Machine LearningBiotechDigital HealthSalt Lake City, US

Andy Olson(Founder)inKristin Brogaard, PhD(Founder)in

Co-investorsMedMountain VenturesPortfoliaUtah Innovation FundAlliance of Angels

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.